[REGN] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
05-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 61.72%
YoY- -26.20%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 1,220,122 1,137,422 725,788 597,027 427,687 102,833 105,979 50.21%
PBT 365,881 393,289 176,078 225,684 191,468 -61,803 -31,641 -
Tax 101,077 182,891 96,358 84,378 -517 562 -906 -
NP 264,804 210,398 79,720 141,306 191,468 -62,365 -33,875 -
Tax Rate -27.63% -46.50% -54.72% -37.39% 0.27% - - -
Total Cost 955,318 927,024 646,068 455,721 236,219 165,198 139,854 37.70%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 21.70 18.50 10.98 23.67 44.77 -60.65 -31.96 -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS 2.53 2.04 0.83 1.44 2.02 -0.68 -0.41 -
EPS Diluted 2.27 1.82 0.73 1.25 1.72 -0.68 -0.41 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.